Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Human Reproduction (Oxford, England)
|
July 24, 2015
The sub-optimal response to controlled ovarian stimulation: manageable or inevitable?
F J Broekmans
Facts, Views & Vision in Obgyn
|
December 6, 2014
Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view
F J Broekmans
Human Reproduction (Oxford, England)
|
November 1, 1996
GnRH agonists and uterine leiomyomas
F J Broekmans
Gynecologic and Obstetric Investigation
|
September 14, 2004
Female age in ART: when to stop?
F J Broekmans, E R Klinkert
Endocrine
|
December 23, 2006
Diagnostic criteria for polycystic ovarian syndrome
F J Broekmans, B C J M Fauser
Maturitas
|
January 1, 1999
Age at menopause as a marker of reproductive ageing
E R te Velde, M Dorland, F J Broekmans
Endocrine Reviews
|
July 11, 2009
Ovarian aging: mechanisms and clinical consequences
F J Broekmans, M R Soules, B C Fauser
Human Reproduction (Oxford, England)
|
November 1, 2000
Use of ultrasound guidance during embryo transfer
R J Rijnders, B W Mol, F J Broekmans
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
September 1, 1992
Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR
F J Broekmans, R E Bernardus, G Berkhout, et al.
Fertility and Sterility
|
December 9, 1997
Predictive value of serum inhibin-B for ART outcome?
L F Bancsi, F J Broekmans, E R te Velde
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Human Reproduction (Oxford, England)
|
July 24, 2015
The sub-optimal response to controlled ovarian stimulation: manageable or inevitable?
F J Broekmans
Facts, Views & Vision in Obgyn
|
December 6, 2014
Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view
F J Broekmans
Human Reproduction (Oxford, England)
|
November 1, 1996
GnRH agonists and uterine leiomyomas
F J Broekmans
Gynecologic and Obstetric Investigation
|
September 14, 2004
Female age in ART: when to stop?
F J Broekmans, E R Klinkert
Endocrine
|
December 23, 2006
Diagnostic criteria for polycystic ovarian syndrome
F J Broekmans, B C J M Fauser
Maturitas
|
January 1, 1999
Age at menopause as a marker of reproductive ageing
E R te Velde, M Dorland, F J Broekmans
Endocrine Reviews
|
July 11, 2009
Ovarian aging: mechanisms and clinical consequences
F J Broekmans, M R Soules, B C Fauser
Human Reproduction (Oxford, England)
|
November 1, 2000
Use of ultrasound guidance during embryo transfer
R J Rijnders, B W Mol, F J Broekmans
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
September 1, 1992
Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR
F J Broekmans, R E Bernardus, G Berkhout, et al.
Fertility and Sterility
|
December 9, 1997
Predictive value of serum inhibin-B for ART outcome?
L F Bancsi, F J Broekmans, E R te Velde
Page
of 6